These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 19944515)

  • 1. Effects of abciximab on postresuscitation microcirculatory dysfunction after experimental cardiac arrest in rats.
    Padosch SA; Teschendorf P; Fuchs A; del Valle y Fuentes D; Peter C; Popp E; Schneider A; Böttiger BW; Walther A
    Resuscitation; 2010 Feb; 81(2):255-9. PubMed ID: 19944515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of activated protein C on post cardiac arrest microcirculation: an in vivo microscopy study.
    Teschendorf P; Padosch SA; Del Valle Y Fuentes D; Peter C; Fuchs A; Popp E; Spöhr F; Böttiger BW; Walther A
    Resuscitation; 2009 Aug; 80(8):940-5. PubMed ID: 19487065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycoprotein IIB/IIIA-inhibition and microcirculatory alterations during experimental endotoxemia--an intravital microscopic study in the rat.
    Walther A; Czabanka M; Gebhard MM; Martin E
    Microcirculation; 2004; 11(1):79-88. PubMed ID: 15280099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro measurement of platelet glycoprotein IIb/IIIa receptor blockade by abciximab: interindividual variation and increased platelet secretion.
    Rossi F; Rossi E; Pareti FI; Colli S; Tremoli E; Gallo L
    Haematologica; 2001 Feb; 86(2):192-8. PubMed ID: 11224490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-resuscitation myocardial microcirculatory dysfunction is ameliorated with eptifibatide.
    Kern KB; Sasaoka T; Higashi H; Hilwig RW; Berg RA; Zuercher M
    Resuscitation; 2011 Jan; 82(1):85-9. PubMed ID: 20950922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The GP IIb/IIIa inhibitor abciximab (ReoPro) decreases activation and interaction of platelets and leukocytes during in vitro cardiopulmonary bypass simulation.
    Straub A; Wendel HP; Azevedo R; Ziemer G
    Eur J Cardiothorac Surg; 2005 Apr; 27(4):617-21. PubMed ID: 15784360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of glycoprotein IIb-IIIa receptor antagonism on platelet membrane glycoproteins after coronary stent placement.
    Gawaz M; Ruf A; Neumann FJ; Pogátsa-Murray G; Dickfeld T; Zohlnhöfer D; Schömig A
    Thromb Haemost; 1998 Dec; 80(6):994-1001. PubMed ID: 9869173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incomplete inhibition of platelet aggregation and glycoprotein IIb-IIIa receptor blockade by abciximab: importance of internal pool of glycoprotein IIb-IIIa receptors.
    Gawaz M; Ruf A; Pogatsa-Murray G; Dickfeld T; Rüdiger S; Taubitz W; Fischer J; Müller I; Meier D; Patscheke H; Schömig A
    Thromb Haemost; 2000 Jun; 83(6):915-22. PubMed ID: 10896249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of anisodamine on microcirculation of the asystole rats during the cardiopulmonary resuscitation].
    Jia LJ; Chen W; Shen H; Ji D; Zhao XM; Liu XH
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2008 Dec; 20(12):737-9. PubMed ID: 19111123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Initial experience with an intravenous P2Y12 platelet receptor antagonist in patients undergoing percutaneous coronary intervention: results from a 2-part, phase II, multicenter, randomized, placebo- and active-controlled trial.
    Greenbaum AB; Grines CL; Bittl JA; Becker RC; Kereiakes DJ; Gilchrist IC; Clegg J; Stankowski JE; Grogan DR; Harrington RA; Emanuelsson H; Weaver WD
    Am Heart J; 2006 Mar; 151(3):689.e1-689.e10. PubMed ID: 16504633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of GP IIb/IIIa inhibitors on vascular inflammation, coronary microcirculation, and platelet function.
    Kereiakes DJ
    Rev Cardiovasc Med; 2006; 7 Suppl 4():S3-11. PubMed ID: 17224889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occupancy of the internal and external pools of glycoprotein IIb/IIIa following abciximab bolus and infusion.
    Quinn MJ; Murphy RT; Dooley M; Foley JB; Fitzgerald DJ
    J Pharmacol Exp Ther; 2001 May; 297(2):496-500. PubMed ID: 11303035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microcirculatory effects of abciximab and eptifibatide: a critical appraisal.
    Kereiakes DJ
    J Invasive Cardiol; 2003 Sep; 15(9):481-3. PubMed ID: 12947205
    [No Abstract]   [Full Text] [Related]  

  • 14. Quantification of abciximab-induced platelet inhibition is assay dependent: a comparative study in patients undergoing percutaneous coronary intervention.
    Furman MI; Kereiakes DJ; Krueger LA; Mueller MN; Broderick TM; Schneider JF; Howard WL; Fox ML; Barnard MR; Frelinger AL; Michelson AD
    Am Heart J; 2003 Feb; 145(2):e6. PubMed ID: 12595861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the glycoprotein IIb/IIIa antagonist abciximab on thrombus formation and platelet function in cats with arterial injury.
    Bright JM; Dowers K; Powers BE
    Vet Ther; 2003; 4(1):35-46. PubMed ID: 12756634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abciximab (ReoPro) removal with a hemoconcentrator during cardiopulmonary bypass.
    Lemmer JH
    J Thorac Cardiovasc Surg; 1999 Nov; 118(5):980-1. PubMed ID: 10534719
    [No Abstract]   [Full Text] [Related]  

  • 17. c7E3 Fab inhibits low shear flow modulated platelet adhesion to endothelium and surface-absorbed fibrinogen by blocking platelet GP IIb/IIIa as well as endothelial vitronectin receptor--results from patients with acute myocardial infarction and healthy controls.
    Reininger AJ; Agneskirchner J; Bode PA; Spannagl M; Wurzinger LJ
    Thromb Haemost; 2000 Feb; 83(2):217-23. PubMed ID: 10739376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of the platelet glycoprotein IIb/IIIa inhibitor abciximab in Chinese patients undergoing high-risk angioplasty.
    Chen YH; Chen JW; Wu TC; Ding PY; Wang SP; Chang MS
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Jan; 63(1):8-15. PubMed ID: 10645045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression of inducible nitric oxide synthase in the carotid of rats after endothelial skinning: the effects of platelets and treatment with abciximab].
    González-Fernández F; Rodríguez-Feo JA; Farré J; Guerra J; Romero J; Gómez J; Rico L; Ayala R; Marcos P; Sánchez de Miguel L; Casado S; López-Farré A
    Rev Esp Cardiol; 1999 Jun; 52(6):422-8. PubMed ID: 10373776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety, inhibition of platelet aggregation and pharmacokinetics of Fab'2 fragments of the anti-glycoprotein IIb-IIIa monoclonal antibody FRaMon in high-risk coronary angioplasty.
    Mazurov AV; Pevzner DV; Antonova OA; Byzova TV; Khaspekova SG; Semenov AV; Vlasik TN; Samko AN; Staroverov II; Ruda MY
    Platelets; 2002 Dec; 13(8):465-77. PubMed ID: 12487780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.